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Background: Mayotte, a small island in the Indian Ocean, has been affected for many years by vector-borne
diseases. Malaria, Bancroftian filariasis, dengue, chikungunya and Rift Valley fever have circulated or still circulate on
the island. They are all transmitted by Culicidae mosquitoes. To limit the impact of these diseases on human health,
vector control has been implemented for more than 60 years on Mayotte. In this study, we assessed the resistance
levels of four major vector species (Anopheles gambiae, Culex pipiens quinquefasciatus, Aedes aegypti and Aedes
albopictus) to two types of insecticides: i) the locally currently-used insecticides (organophosphates, pyrethroids)
and ii) alternative molecules that are promising for vector control and come from different insecticide families
(bacterial toxins or insect growth regulators). When some resistance was found to one of these insecticides, we
characterized the mechanisms involved.
Methods: Larval and adult bioassays were used to evaluate the level of resistance. When resistance was found, we
tested for the presence of metabolic resistance through detoxifying enzyme activity assays, or for target-site
mutations through molecular identification of known resistance alleles.
Results: Resistance to currently-used insecticides varied greatly between the four vector species. While no
resistance to any insecticides was found in the two Aedes species, bioassays confirmed multiple resistance in Cx.
p. quinquefasciatus (temephos: ~ 20 fold and deltamethrin: only 10% mortality after 24 hours). In An. gambiae,
resistance was scarce: only a moderate resistance to temephos was found (~5 fold). This resistance appears to be
due only to carboxyl-esterase overexpression and not to target modification. Finally, and comfortingly, none of the
four species showed resistance to any of the new insecticides.
Conclusions: The low resistance observed in Mayotte’s main disease vectors is particularly interesting, because it leaves a
range of tools useable by vector control services. Together with the relative isolation of the island (thus limited
immigration of mosquitoes), it provides us with a unique place to implement an integrated vector management plan,
including all the good practices learned from previous experiences.
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Mayotte is a French island located in the Indian Ocean, in
the Comoros archipelago. For many years, this island has
been heavily affected by vector-borne diseases. Historically,
the two diseases that mainly plagued the island were
Bancroftian filariasis, mostly transmitted by Culex pipiens
quinquefasciatus [1-4], and malaria, transmitted by several
anopheline species, including Anopheles gambiae s.s. [5,6].
Today, malaria is still present in Mayotte, although the
number of cases has significantly decreased during the last
two years [7]. Moreover, while the disease was considered
eliminated from the island, some cases of Bancroftian filar-
iasis were recently recorded [8].
In addition to these endemic diseases, a major dengue
fever outbreak in 1943 [9] and a chikungunya outbreak
in 2005 and 2006 have also affected Mayotte [10]. Both
are due to arboviruses transmitted by Aedes species.
However, while dengue was principally transmitted by
Aedes aegypti, chikungunya main vector was Ae. albo-
pictus [11]. This last species, observed for the first time
on the island in 2001 [12], has since almost completely
replaced Ae. aegypti [13], and certainly played the main
role in the recently recorded cases of dengue and chi-
kungunya [14]. Finally, new arboviruses recently started
to circulate on the island, including the Rift Valley Fever
virus [15].
To limit the impact of these diseases on people from
Mayotte, many vector control programs have been im-
plemented since the early 50s [16]. Most of the efforts
were intended to control Cx. p. quinquefasciatus and
An. gambiae populations, to prevent filariasis and mal-
aria. They relied almost entirely on the use of chemical
insecticides (from the organochlorines (OC), organophos-
phates (OP) and pyrethroids (PYR) families), through
extensive applications on larval breeding sites, indoor re-
sidual spraying treatments (IRS) [3,5,9,16-18] and, more
recently, long-lasting insecticide treated nets (LLIN).
These vector control campaigns have had good results
and greatly limited the impact of lymphatic filariasis and
malaria in Mayotte [4,6]. Today however, several con-
straints could impede vector control. The first constraint
is administrative, with a significant reduction of the num-
ber of insecticides available for vector control due to
new Europeana regulations [19]. All pesticide molecules
had indeed to be re-examined in 2007 for marketing
authorization, through a costly application filed by the
producers; some unprofitable yet efficient molecules
were not supported. There are also technical difficulties,
due to the increasing role of Ae. albopictus as a major
vector of arboviruses in Mayotte. Due to their prefer-
ences for confined larval breeding sites (natural, like
tree holes, or artificial, like used tires) and their eggs re-
sistant to desiccation [20,21], Ae. albopictus is particu-
larly difficult to reach through conventional sprays ofinsecticides. The third type of constraints is ecological:
Mayotte is a small island with a specific ecosystem
encompassing many endemic species, and as such must
be protected from anthropic pollutions. The effects of
insecticide treatments on non-target fauna and their
potential accumulation in the food chain need to be
taken into account and limited. Finally, the last and
most important challenge come from evolutionary process:
the long-term use of insecticides is known to select
for resistance of the target insects, with the possible
effect of rendering the available molecules ineffective
for control [22].
However, in Mayotte, almost nothing was known on the
resistance status of the various mosquito vectors, until a re-
cent study on Cx. p. quinquefasciatus [23]. This study
showed that many resistance mechanisms were present in
this species, so that the lack of data for the other vectors
became a major concern. In view of the history of insecti-
cide treatments in the island, many resistance mechanisms
could have been selected in the other species as well, and
could prevent efficient vector control measures. There are
indeed a large number of insecticide resistance mechanisms
in mosquitoes, mainly through metabolic resistances or in-
secticide target modifications (review in: [24-26]). The usual
way of overcoming resistance is to change the molecule
used to restore efficient vector control. However, the num-
ber of new molecules available is continuously shrinking
[27], and cross-resistance (i.e. the fact that one resistance
mechanism is able to confer resistance to other molecule
families) could lead to an additional reduction of alterna-
tives [28].
All these constraints have to be considered to implement
a rational and sustainable vector control plan. In this type
of plan, it is clearly important to monitor the resistance
levels to currently-used insecticides and to assay the few
valuable and authorized molecules that could replace them
in case of insecticide resistance development in the targeted
vectors.
In this study, the four main mosquito vectors of the is-
land (Cx. p. quinquefasciatus, An. gambiae, Ae. aegypti
and Ae. albopictus) were thus investigated to determine
their levels of resistance to the insecticides currently used
in Mayotte: temephos (OP), Bti (bacterial toxins (BacT)
extracted from Bacillus thuringiensis var israelensis), and
deltamethrin (PYR). When resistance was found, the mech-
anisms involved were characterized through biochemical
and molecular analyses. In addition, resistance to four
candidate insecticides for vector control in Mayotte was
also assayed: spinosad, an insecticide of bacterial origin
(Spinosyns), and three insect growth regulators or IGRs,
diflubenzuron, pyriproxyfen and methopren. The results
are discussed in the light of the vector control strategies
usable to prevent emergence and spread of resistance in
the island vectors.
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Mosquito samples and strains
Five laboratory strains were used in this study: An. gambiae
KIS strain [29], Cx. p. quinquefasciatus SLAB strain [30],
Ae. aegypti BORA strain [31] and Ae. albopictus PLP strain
[32] were used as susceptible reference strains; the An.
gambiae AcerKIS strain [33], homozygous for the G119S
mutation of acetylcholinesterase [34], was used as the OP-
resistant reference strain in this species.
Field larvae of An. gambiae, Cx. p. quinquefasciatus,
Ae. aegypti and Ae. albopictus were collected in Mayotte
between 2010 and 2011. Natural populations (Figure 1)
were sampled from a garbage dump in Dzoumogné for
An. gambiae (DZOU), an open sewer in Tsoundzou for
Cx. p. quinquefasciatus (TZ1), several peri-domestic
breeding sites in Petite Terre for Ae. aegypti (PT) and a
stock of used tires in Kaweni for Ae. albopictus (KWI).
The larvae of An. gambiae and Cx. p. quinquefasciatus
were collected at early instars (1st or 2nd), reared in the
laboratory to 3rd instar, and used for bioassays. The
larvae of Ae. aegypti and Ae. albopictus were reared to
adulthood in the laboratory. Mono-specific colonies ofFigure 1 Sampled populations in Mayotte. Sampling was carried
out in Dzoumogné for the DZOU colony of An. gambiae, in
Tsoundzou 1 for TZ1 colony of Cx. p. quinquefasciatus, in Kaweni for
KWI colony of Ae. albopictus and in Petite Terre for PT colony of
Ae. aegypti.Ae. aegypti and Ae. albopictus were established, and fe-
males were blood-fed to obtain F1 offsprings, which
were used for bioassays (3rd-instar larvae). In Cx. p.
quinquefasciatus, Ae. aegypti and Ae. albopictus samples,
some of the field larvae were kept, reared, and the adults
were bred in the laboratory to establish TZ1, PT and
KWI colonies. These colonies were used for IGR bioas-
says. Due to technical difficulties for establishing an An.
gambiae colony from field individuals, IGR bioassays
were directly performed on field-collected larvae.
Finally, to overcome the difficulties to establishing an
An. gambiae colony while remaining close to the original
field population (as for the other species), the DZOU
temephos resistance gene(s) were introgressed into the
genome of the KIS strain, leading to the DZKIS strain.
DZOU males were crossed with unmated females of the
KIS strain and their progeny reared in the laboratory.
Third-instar larvae were selected with temephos at a
dose killing 80% of the individuals. Male survivors were
backcrossed on females of the KIS strain and selected
again. The following generations were then left to cross
among themselves, 3rd-instar larvae being selected with
temephos at each generation, until the resistance level
had stopped increasing (10 generations). This protocol
provided the DZKIS strain, containing mainly DZOU
genome (the field population colony), and just enough
KIS genome to be lab-adapted. It also resulted in a strain
more homogeneous in terms of resistance.
Bioassays
Larval and adult bioassays were performed following WHO
protocols [35,36]. Larval bioassays were carried out using
ethanol solutions of the following active ingredients, teme-
phos (OP), chlorpyrifos (OP), malathion (OP), propoxur
(carbamate, or CM), spinosad (Spinosyns), diflubenzuron
(IGR), pyriproxyfen (IGR) and methopren (IGR) (spinosad
from Dow Agro Sciences, Indianapolis, USA; other prod-
ucts from Sigma-Aldrich, Germany), and using water solu-
tions of Bti (BacT) formulation (Vectobac 12AS, 1200 ITU/
mg). Larval bioassays were conducted on sets of 25 early
3rd-instar larvae placed in a cup with 99 ml of water. One
ml of the tested insecticide solution was then added in each
cup. Assays of four to nine doses in a minimum of two
cups per dose were performed for each insecticide. Two
replicates were performed for temephos, spinosad and Bti,
and one or two replicates were performed for chlorpyrifos,
malathion, propoxur and IGR insecticides (it results in 250
to 1500 mosquitoes assayed for each insecticide). In teme-
phos, spinosad, chlorpyrifos, malathion, propoxur and Bti
assays, larval mortality was recorded after 24 hours of in-
secticide exposure. For IGR assays, the total number of lar-
vae in each cup was recorded after 24 hours and the
number of emerging adults was recorded daily. Emergence
Inhibition (EI) is calculated for each dose by subtracting the
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the beginning of the test. Note that in such IGR tests, regu-
lar feeding of larvae is required, due to their duration (over
10 days). For Aedes and Culex larvae, 3 to 5 mg per cup of
a mixture of dog and fish foods were added every day. For
Anopheles larvae, 0.5 to 1.5 mg per cup of fish food were
added on the surface. The quantity of food was decreased
at the appearance of the first pupae, as some larvae were
still feeding.
Adult bioassays were carried out using WHO test
tubes. This device allows exposing sets of 25 adult fe-
males (2–5 days old) to a filter paper impregnated with
deltamethrin at a dose of 0.05% (products from Sigma-
Aldrich, Germany). This diagnostic dose kills 100% of
individuals in a susceptible population [37]. Four sets of
25 females were exposed for 60 minutes to deltamethrin
to evaluate its knockdown effect (KD) on each colony or
strain. Mortality was recorded after 24 hours. Two repli-
cates per colony/strain were performed.
The analyses of dose-mortality responses were per-
formed using the R software [38]. The R script BioRssay
was used; it is freely available on the website of the Insti-
tut des Sciences de l’Evolution de Montpellier [39]. This
script computes the doses of insecticide killing 50% and
95% of the tested colony or strain (Lethal Concentration
50 and 95, or LC50 and LC95) and the associated confi-
dence intervals, using a script modified from Johnson
et al. [40], which allows taking into account the hetero-
geneity of the data [41]. Mortality in controls is taken
into account using the correction from the Abott’s for-
mula [42]. A generalized linear model (GLM) with a bi-
nomial error and a probit link is then fitted to the data
where the probit mortality is a function of the logarithm
of the dose of insecticide for each colony/strain. The
script also computes the slope and intercept of the re-
gression for each colony/strain (and their standard er-
rors), and tests for the linearity of the dose-mortality
response (χ2 test). Finally, it allows the comparison of
two or more strains or colonies and calculates the resist-
ance ratios, i.e. RR50 or RR95 (=LC50 or LC95 of tested
colony/LC50 or LC95 of the reference strain, resp.) and
their 95% confidence intervals. A RR in which the confi-
dence interval does not include 1 was considered as
statistically significant, so that the tested colony was
significantly more resistant than the reference. Note,
however, that even slight differences between colonies/
strains can be statistically significant, due to the high
number of mosquitoes tested. However, even a statisti-
cally significant RR < 3 is usually considered of limited
biological significance (such RR can be obtained when
comparing susceptible strains, e.g. [43]), and we applied
this criterion here. The script then builds custom graphs
and a summary text file with the different parameters and
tests is provided.The same script was used to calculate the Emergence
Inhibition Concentrations for IGR insecticides (EIC50
and EIC95) and the KnockDown Times for deltamethrin
(KDT50 and KDT95).
Metabolic resistance
Biochemical tests were performed on single 2–5 days-
old females from the An. gambiae DZOU colony to
evaluate the activity of the main families of detoxifying
enzymes. Protein amount was quantified in microplates
using the method of Bradford [44], the quantity or activ-
ity of the different detoxifying enzymes were expressed
per mg of protein present in the homogenate or quantity
of molecules metabolized per minute, respectively. Cyto-
chrome P450 monooxygenases (named mixed function
oxidases or MFO) were quantified indirectly by the per-
oxidase activity of the heme group with tetramethylben-
zidine (note that all hemoproteins are thus quantified,
not only MFO; [45]). Carboxyl-esterases (COE) were
quantified indirectly by their ability to hydrolyze α-
naphthyl and β-naphthyl acetate [46].
Statistical comparisons of detoxifying enzyme activities
present in the An. gambiae susceptible strain KIS and
the DZOU colony were computed using Mann–Whitney
tests with the Statistica software [47].
Analyses of target-site modifications
Total DNA of single mosquitoes of the An. gambiae
DZOU colony was extracted using the CTAB protocol
[48]. The G119S mutation, carried by the ace-1R allele of
the acetylcholinesterase-1 gene (AChE1), was investi-
gated using the PCR-RFLP test described by Weill et al.
[49]. Two substitutions in the kdr gene are known to
cause resistance to PYR in An. gambiae: L1014F and
L1014S, respectively most often encountered in West
Africa and East Africa. They were investigated using the
multiplex-PCR described in Martinez-Torres et al. [50]
and Ranson et al. [51], respectively. We thereafter called
these two alleles kdrR, indifferently. Only the L1014F
mutation was found in Culex quinquefasciatus from
Mayotte, where it was investigated in our precedent study
[23], using the multiplex-PCR described in Martinez-Torres
et al. [52]. The resistance allele was called kdrR thereafter.
Results and discussion
No resistance observed in Ae. aegypti and Ae. albopictus
Larval bioassays revealed that colonies from field popu-
lations of Ae. aegypti and Ae. albopictus (PT and KWI,
respectively) did not show biologically significant resist-
ance to any of the tested larvicides (RR between 0.3 and
1.6, Figure 2 and Additional file 1). Similarly, adult bio-
assays to deltamethrin showed a complete susceptibility
of these two species (over 97% mortality 24 hours after
Figure 2 Insecticide resistance in vector mosquitoes from Mayotte. The resistance ratios (RR50, i.e. the ratios of LC50 of the tested colonies
over the LC50 of the susceptible reference strain), of colonies from field populations of Ae. aegypti (gray), Ae. albopictus (purple) Cx. p.
quinquefasciatus (red) and An. gambiae (orange) to different tested insecticides are presented. The error bars represent the confidence interval of
RR at 95%. The solid red line represents RR = 1 (i.e. a LC50 equal to that of the susceptible reference) and the dotted red line represents RR = 3
(resistance is considered of biological significance when above). RR significantly higher than 1 (i.e. when CI95 does not include 1) are indicated by
a star.
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served as compared to the susceptible reference strains
(RR between 0.9 and 1, Figure 2 and Additional file 2).
The susceptibility of these two Aedes species to IGRs,
Spinosad and Bti is not surprising because these insecti-
cides have never been used on the island before 2011
([16]; Belon, personal communication). Since 2011, Bti
has been used by the vector control service of Mayotte
as a larvicide, but not against Aedes species.
In contrast, temephos (larvicide) was used in Mayotte
from 1973 to 2012 and deltamethrin (adulticide) has
been used since 1984 ([16], Belon, personal communica-
tion), but no resistance was observed in either Ae.
aegypti or Ae. albopictus. Several factors may explain the
absence of resistance to deltamethrin and temephos in
these two species. First, before the 2005–2006 chikun-
gunya outbreak [10], these species were not targeted by
vector control treatments. Since the epidemic, control
against these two vectors is essentially based on social
mobilization and physical destruction of breeding sites.
Only few insecticide treatments have therefore been car-
ried out specifically against Aedes species in Mayotte.
Secondly, their main breeding sites are peri-domestic
containers used for water storage and small water collec-
tions in peri-urban areas (coconut, dead leaves, used
tires, etc. [20,21]). These soil-less breeding sites are little
affected by environmental xenobiotic contamination (in-
secticides or pollutants) and difficult to reach by the
vector-control teams. Thirdly, deltamethrin is used in
Mayotte either in Indoor Residual Spraying (IRS), or on
Long Lasting Insecticide-treated Nets (LLIN). These twomodes of treatment target adult female mosquitoes, but
only indoors. Ae. albopictus and Ae. aegypti being diur-
nal and exophagous species [53,54], they are therefore
not likely to be affected by LLINs, which protect people
when sleeping. In addition, Ae. albopictus is an exophilic
species [54], and although Ae. aegypti females can rest
indoors, they do so preferentially on untreated surfaces
[55,56], so that IRSs have little effect on these species.
Overall, Ae. albopictus and Ae. aegypti are therefore
likely to be subject to weak selection, which probably ex-
plains their complete susceptibility. This situation is rad-
ically different from that observed for some other
French islands. For example, on the Martinique island,
Ae. aegypti is the main target of vector control interven-
tions, and this species presents strong levels of PYR re-
sistance in this place [57]. A final remark concerning
insensitive acetylcholinesterase target of OP and CM: it
has been shown that, in these two Aedes species, the
G119S mutation of this enzyme is highly unlikely, due to
molecular constraints [58]. It was thus not surprising
that this particular type of resistance was lacking, and it
is unlikely to evolve in the future.
High levels of resistance in Cx. p. quinquefasciatus
The results for Cx. p. quinquefasciatus are in sharp con-
trast to those of the two Aedes species. Larval and adult
bioassays on TZ1 colony indeed revealed strong resist-
ance respectively to temephos (RR50 = 17.2, RR95 = 18.9;
Figure 2 and Additional file 1) and to deltamethrin (10%
of mortality after 24 hours and a strong decrease of
knockdown effect: RR50 = 4.2, RR95 = 4.9; Figure 2 and
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sistance to any of the other tested insecticides has been
identified in this colony (RR50 between 0.9 and 1.5, Figure 2
and Additional file 1), even if TZ1 colony showed a low
resistance at LC95 to juvenile hormone analogs (pyriproxy-
fen and methopren, RR95 = 4.9 and 4.1 respectively).
The resistance mechanisms of Cx. p. quinquefasciatus
in Mayotte have been studied in depth recently (see
[23]). Two mechanisms of resistance to OPs were found
on the island. The first was an overexpression of ester-
ases, encoded by the Ester2 allele, and the second was a
modification of the AChE1, due to the G119S mutation
of the gene ace-1. Both were found at relatively high fre-
quencies (0.59 for Ester2 and 0.39 for ace-1R; [23]). Simi-
larly, the kdrR allele, coding for a modification of the
sodium channels allowing resistance to PYRs was found
almost fixed on the entire island (kdrR frequency = 0.98).
Biochemical tests and bioassays with synergists did not
reveal MFO involvement in PYR resistance [23]. The
kdrR allele thus appeared to be the main allele respon-
sible for deltamethrin resistance, although the involve-
ment of other metabolic resistance cannot be excluded.
The low resistance to juvenile hormone analogues ob-
served at the high doses could thus be due to the over-
production of esterases in this colony [23], as described
in other insect species [59].
Cx. p. quinquefasciatus is the major vector of the Ban-
croftian filariasis, which has been plaguing Mayotte for
many years [1,2,4]. Since the 50s, intense vector control
efforts have been carried out against this species [16].
Many neurotoxic insecticides targeting AChE1 (OPs)
and sodium channels (DDT followed by PYRs) have been
used to control it [3,5,16-18]. These important selective
pressures certainly explain the strong resistance to teme-
phos and deltamethrin observed in the TZ1 colony. Such
strong resistance to PYRs and OPs is not an isolated
case in the Indian Ocean. Indeed, this species has been
shown to also harbor major resistance mechanisms to
PYR, OP and OC insecticides in Mauritius, Madagascar
and La Réunion [23,32]).
The susceptibility of Cx. p. quinquefasciatus to Bti and
spinosad and the low resistance to IGRs are probably re-
lated, similar to the Aedes species, in the fact that these
insecticides have not been used in the past in Mayotte.
They thus provide interesting alternatives to circumvent
the high resistance to the insecticides classically used
against Culex.
An original temephos resistance mechanism in An.
gambiae
An. gambiae has always been the main target of insecticide-
based vector control in Mayotte, as malaria has been
endemic on the island for many years [5,9,16,17,60]. In the
DZOU colony, a significant resistance to temephos (RR50 =4.8, RR95 = 12.9; Figure 2 and Additional file 1) was ob-
served but there was no biologically significant resistance to
any of the other insecticides (RR between 0.2 and 2).
Whereas the absence of resistance is expected for the
larvicides that have never been used in the island before
2011 (Bti, spinosad, IGRs), absence of resistance to the
adulticide deltamethrin is particularly striking (over 99%
mortality after 24 hours, and full susceptibility to knock-
down effect, RR between 1 and 1.1, Figure 2 and
Additional file 2). Surprisingly, PCR performed on An.
gambiae adult mosquitoes of the DZOU colony did not
show either any known kdr resistance mutation, neither
the western (L1014F substitution: N = 31, all susceptible
homozygous) nor the eastern (L1014S substitution: N =
28, all susceptible homozygous). Insecticides that target
the sodium channel have indeed been used in Mayotte
since the early 70s and are still currently used. DDT
(OC) was first used in 1973, to be replaced by delta-
methrin (PYR) in the early 80s [16]. In several cases, the
development of An. gambiae s.s. insecticide resistance
has been associated with selection pressures related to
the control of agricultural pests [29,61,62], but in
Mayotte there are no areas of intense agriculture. One
hypothesis to explain the lack of kdrR alleles is thus that
the selection pressure coming only from public health is
not enough to maintain these alleles at a detectable level
in natural populations. Furthermore, Mayotte is a rela-
tively isolated island and a second hypothesis is that no
importation of a kdrR resistance allele has yet taken
place. The fact that so far no kdrR mutation has been re-
ported in An. gambiae populations from the closest
islands, especially in Madagascar [24,63], gives support
to this second hypothesis.
As temephos has been used since 1973 in the island
[16,17], the resistance to this insecticide observed in the
DZOU colony is more expected. To better understand
the mechanism(s) involved, the DZOU colony was partly
introgressed in the reference susceptible strain KIS and
selected at each generation with temephos, thereby cre-
ating the DZKIS strain, which carries a mainly DZOU
genome but is able to be maintained in the laboratory.
The results of this introgression are presented Figure 3.
DZKIS temephos resistance was significantly higher than
in DZOU sample at LC50 (RR50 = 6.9 and 4.8, respect-
ively; Additional file 3), but lower at LC95 (RR95 = 3.5
versus 12.9, respectively; Additional file 3). This observa-
tion was mainly due to an increase of the slope of the
dose-mortality regression between DZOU and DZKIS
(1.75 and 7.58 respectively), reflecting a greater genetic
homogeneity in the selected strain (due to selection at
each generation). Tests carried out on DZKIS with other
insecticides that target the AChE1 (Additional file 3) did
not show biologically significant cross-resistance to chlor-
pyrifos (OP, RR50 = 1.2) and to malathion (OP, RR50 = 2.2).
Figure 3 Temephos resistance in the DZKIS strain. The graph shows the evolution of the resistance level to temephos of the DZKIS strain in
the 1st, 6th and 10th (i.e. the last) generations of selection. The dose-mortality of the DZOU original colony and of the KIS and AcerKIS reference
strains (respectively susceptible and resistant to OPs through the G119S ace-1 mutation) are also presented.
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lower than those of AcerKIS, the reference ace-1R strain,
for temephos (OP, RR50 = 6.9 vs 16.4, respectively),
malathion (OP, RR50 = 2.2 vs 21.5, respectively) and pro-
poxur (CM, RR50 = 5.6 vs ≈ 10 000). These results thus
exclude the presence of insensitive AChE1 associated
with G119S mutation. The absence of the ace-1R allele
was confirmed by PCR performed on adult mosquitoes
from the DZOU original sample (N = 30, all homozy-
gous for ace-1 susceptible alleles). The activity or quan-
tity of detoxifying enzymes in adult mosquitoes was
compared between the DZOU sample and the KIS
strain. The activities of α- and β-esterases were signifi-
cantly higher in DZOU than in KIS (respectively, 1.19
and 1.47 fold, Mann–Whitney test: p < 0.001; Figure 4B
and C). In contrast, the global quantity of MFO was sig-
nificantly lower for DZOU than for KIS (0.90 fold,
Mann–Whitney test: p < 0.001; Figure 4A).
In view of these results, it seems that the temephos resist-
ance observed in An. gambiae from Mayotte is mainly due
to COE overexpression or overactivity. Resistance to OPs
and to a lesser extent CMs by COEs is commonly encoun-
tered in insects [64], particularly in mosquito vectors, such
as Culex species [65,66] or Ae. aegypti [57,67,68]. Thisresistance mechanism usually confers a low level of resist-
ance (about 10 fold, [26]), which is consistent with the re-
sistance levels observed in DZOU and DZKIS (temephos
and propoxur, 5 to 10 fold, Additional file 3). Although OP
and CM resistance due to COE has already been reported
in An. gambiae, it has so far always been found associated
to the insensitive AChE1 [69,70], so that the situation in
Mayotte is unique.
The DZOU colony breeding-site was a garbage dump,
where a large variety of pollutants are present. This is a
quite unexpected biotope for this species that usually
prefers clean water collection. Such an environment,
polluted by xenobiotics and organic matter, could have
promoted the selection for an increase of COE expres-
sion, as it has been observed for other resistance mecha-
nisms [71,72]. However, An. gambiae was also directly
targeted by significant OP-based control in Mayotte
[5,16]. The selective pressure generated by these treat-
ments did not lead to the selection of the G119S ace-1
mutation locally, and/or the allele was not imported,
probably thanks to the island isolation (while it is exten-
sively present in West Africa for example [33]). The con-
trast with Cx. p. quinquefasciatus is striking and will
require more studies to be fully understood.
Figure 4 Comparison of detoxification enzyme quantities or activities in single mosquitoes of KIS and DZOU. The amount of cytochrome
P450 oxidase (A) (MFO) is expressed in pmol of P450 Equivalent Unit per mg of protein for each mosquito. Activities of α (B) and β-esterases
(C) (COE) are expressed as nmol of product formed (α or β-naphthol) per minute and per mg of protein.
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vored overexpressed COE selection in the DZOU col-
ony, they might also explain the lower MFO expression
in this strain compared to KIS. Indeed, some OP, such as
temephos, are bio-activated in their oxon form (the toxic
form) by some oxidases, and it has been shown in Cx. p.
quinquefasciatus that MFO were counter-selected in an
environment under temephos pressure [73].
Low resistance in disease vectors: an opportunity for
Mayotte
In light of these results, the resistance status of vectors
in Mayotte offers an unusual situation in the world of
vector control. With the exception of temephos and del-
tamethrin resistances observed in Cx. p. quinquefascia-
tus and of the low temephos resistance in An. gambiae,
the four main mosquito vector species were indeed sus-
ceptible to the majority of new tested insecticides (Bti,
spinosad and two IGRs). Due to very different modes of
action, resistance mechanisms to OPs and CM identified
in An. gambiae and Cx. p. quinquefasciatus, including
COEs, should not confer cross-resistance to these new in-
secticides (except, maybe, for juvenile hormone analogues,
see above). Moreover, temephos has been recently aban-
doned from the arsenal of authorized insecticides for vec-
tor control in France due to European rules [19], and no
other insecticides targeting AChE1 is presently authorized.
As this resistance is costly in terms of fitness (e.g. [74,75]),
they should thus disappear, and should not impact the fu-
ture vector control efforts.
However, in order to preserve this positive situation,
the usual vector control practices should be avoided. In
particular, it is important to not use exclusively a single
insecticide to control mosquitoes. Bti is currently the
only larvicide used for vector control in Mayotte, thanks
to its many advantages: this insecticide is highly specific,
with little effect on non-target organisms [76], and it is a
mixture of several synergistic toxins [77], thus limiting
the risk of resistance development. Unfortunately, resist-
ance has been described in a field population of Cx. p.
pipiens from the United States [78] and resistance to
separate Bti toxins in the laboratory were selected in Ae.
aegypti [79] or Cx. p. quinquefasciatus [80]. Similarly,
only deltamethrin is currently used for adulticides (IRS
and LLINs). Its efficacy is preserved so far by the suscep-
tibility of An. gambiae. However, this absence of resist-
ance to PYRs should be carefully monitored, as it could
rapidly spread through natural selection, following its
appearance by mutation or importation [81]. Finally,
even if other tested insecticides (spinosad and IGRs) are
used less in vector control, examples of resistance to
these compounds already exist in mosquitoes [78,82-84].
The exclusive use of any of those insecticides wouldtherefore lead to the rapid emergence and selection of
resistance in mosquitoes from Mayotte.
To prevent the development of resistance in these dis-
ease vectors, various resistance management strategies
can be used. One of the most efficient strategies is to
alternatively use insecticides with different modes of
action and for which no cross-resistance occur in target
populations [26,27]. Such strategies require a large
enough panel of molecules. This may be a problem since
in Mayotte, as mentioned before, Bti is the only larvicide
currently allowed for use in natural breeding sites with
non-target fauna associated, and deltamethrin the only
adulticide authorized. Moreover, alternatives would be
necessary in case of emergence of resistance. Therefore,
a change in the national, but also European, policies re-
garding pesticides agreement would be much welcome.
Some molecules could be re-authorized to be used only
in case of public-health threat for example. This may be
the case for temephos, which is a handy, low-cost and
relatively safe molecule [85]. Although low resistance to
this insecticide was observed in Mayotte (Anopheles and
Culex), the operational doses could remain mostly ef-
fective against these vectors [86]. This molecule could
thus be used as a back-up in case of emergency. Again,
it is important to stress that such back-up would not
mean using a single molecule in less pressing periods, in
which case emergencies would become the rule.
More generally, the absence of strong resistance in most
vectors allows the local vector control programme to de-
velop a preemptive and reasoned insecticide use strategy in
order to prevent the risk of development of resistance. This
is very positive as such strategies are most often only con-
sidered in dire circumstances, i.e. when resistance is in-
stalled and when they are thus the least effective. However,
the fight against mosquito disease vectors in Mayotte
should not be exclusively based on insecticides, but should
rather follow an Integrated Vector Management strategy
(IVM [87]). This strategy recommends the combination of
several tools to manage vector populations: physical
destruction of breeding sites, social mobilization of com-
munities, entomological monitoring and rational use of in-
secticides by all those implementing any action [26,87]. A
recent study compared 61 vector control interventions
against dengue vectors and showed that interventions
based on IVM were more effective than interventions based
only on environmental management, biological control or
chemical control alone [88]. IVM has already shown good
results against Ae. aegypti in Singapore and Vietnam
[89,90]. This strategy requires the collaboration of several
health sectors (vector control services, epidemiologists,
hospitals), but also of other sectors not directly related to
health (local administration, urbanization development, im-
migration surveys, waste management, etc.). For example,
most of the breeding sites of Cx. p. quinquefasciatus in
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ter management and personal sanitation could greatly re-
duce the number of available breeding sites for this species.
Similarly, the forthcoming closing of the garbage dump of
Dzoumogné would limit the number of breeding sites for
An. gambiae in this area.
Conclusion
Mayotte is an ideal territory to implement an IVM ap-
proach and to carefully anticipate vector control manage-
ment. Indeed, the economic development of the island is
now fast and many public works are ongoing. It would be
relatively easy to integrate the concept of vector manage-
ment in the land and city planning policies. Moreover, so-
cial mobilization is already used by the local vector control
services and is continuously improved. Finally, the low
levels of insecticide resistance observed in the main mos-
quito vectors of the island allow usage of most of the larvi-
cide and adulticide tested here. Thus, only anticipated
resistance management strategies and regular entomo-
logical surveys remain to be implemented. This unusual
situation allows being relatively optimistic about the future
of vector control in Mayotte.
Endnote
aNB: Mayotte has recently become a French overseas
administrative department and has to comply with Bio-
cide Directive 98/8/EC.
Additional files
Additional file 1: Effects of larvicides on mosquito vectors from
Mayotte. Resistance levels of DZOU, TZ1, PT and KWI colonies to
temephos, Bti, spinosad, diflubenzuron, pyriproxyfen and methopren are
compared to resistance levels of the reference strains KIS and AcerKIS,
SLAB, BORA and PLP, respectively. For An. gambiae, additional tests with
chlorpyrifos, malathion and propoxur are presented. N is the total
number of tested larvae. The 50 and 95% lethal concentrations (LC50 and
LC95) and the 50 and 95% emergence inhibition concentrations (EIC50
and EIC95) are expressed in mg/l, with their associated confidence
intervals at 95% (CI95). Finally, the corresponding resistant ratios (RR),
i.e. the ratios of LC or EIC of the tested colony over the susceptible
reference strain, are also indicated and presented in bold when
significantly higher than 1 (i.e. when CI95 does not include 1).
Additional file 2: Effect of deltamethrin on adult vector mosquitoes
from Mayotte. Short-term knockdown effect and mortality at 24 hours
induced by deltamethrin on DZOU, TZ1, PT, KWI colonies and KIS, SLAB,
BORA and PLP reference strains are presented. N is the total number of
tested adult females. The 50 and 95% knockdown times (KDT50 and
KDT95) are expressed in minutes, with their associated confidence
intervals at 95% (CI95). Finally, the corresponding resistant ratios (RR),
i.e. the ratios of KDT of the tested colony over the susceptible reference
strain, are also indicated and presented in bold when significantly higher
than 1 (i.e. when CI95 does not include 1).
Additional file 3: Effects of OP and CM larvicides on Anopheles
gambiae from Mayotte. Resistance levels of the introgressed DZKIS
strain are compared to resistance levels of the reference strains KIS and
AcerKIS for three OP (temephosa, chlorpyrifos, malathion) and one CM
(propoxur) larvicides. N is the total number of tested larvae. The 50 and
95% lethal concentrations (LC50 and LC95) are expressed in mg/l, withtheir associated confidence intervals at 95% (CI95). Finally, the
corresponding resistant ratios (RR), i.e. the ratios of LC of the tested
colony over the susceptible reference strain, are also indicated and
presented in bold when significantly higher than 1 (i.e. when CI95 does
not include 1).
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